Thyme Care

Thyme Care

Private
Nashville, TennesseeHealthcare & Life Scienceshttps://www.thymecare.com

Last Round

Series D

Sep 25, 2025

Est. Valuation

$1B

Total Funding Raised

$274M

Company Overview

Thyme Care is a healthcare technology company that provides an oncology care platform to support cancer patients throughout their treatment journey with physician-guided nursing and resource specialists, enhancing access to quality care and actionable insights for early intervention.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Telemedicine, Vertical SaaS

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

cancer care navigationvalue-based careoncology managementoncology benefits managementshared savings modeltwo-sided risktotal cost of carecancer care carve-outcare management platformEnhancing Oncology ModelEOMMedicare AdvantageAI-powered navigationtech-enabled servicefinancial toxicityPer-Employee-Per-MonthPEPM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thyme Care Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Thyme Care Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DSep 25, 2025
DebtJul 16, 2024
Series CJul 16, 2024
Series BAug 22, 2023
Series AOct 5, 2021

Key People

Founding team and executive leadership

Robin Shah

Co-Founder, Chief Executive Officer

Founding Team

Bradford Diephuis

President And Chief Operating Officer

Executive Team

Jesse Waldron

Chief Financial Officer

Executive Team

Thyme Care Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries A
Town Hall VenturesSeries C, Series B, Series D
AlleyCorpSeries C, Series B, Series A, Series D
Frist Cressey VenturesSeries C, Series B, Series A, Series D
Texas OncologySeries D
Foresite CapitalSeries C, Series B, Series D
Morgan HealthSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2026

    Ranked No. 20 on Inc. Regionals: Southeast list.

  • Mar 24, 2026

    Employs a growing nursing workforce of over 250 registered nurses.

Thyme Care Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Thyme Care Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Thyme Care's valuation, stock price, and market status.

Firmographic Details

HeadquartersNashville, Tennessee
Employee Range460
Year Founded2020
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.